AzTrials
AzTrials

Major Adverse Cardiac Event (MACE)NCT07162376

How Clinical and Personal Information Shape Physicians' Risk Judgments

A study testing Personal Information Disclosure in people with Major Adverse Cardiac Event (MACE), run by University of Maryland, College Park at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Physicians often form quick judgments about the risk for serious disease when interacting with patients. Underestimating risk can lead to underuse of diagnostic testing and untreated illness, which can worsen patient outcomes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Major Adverse Cardiac Event (MACE)
What is being tested?
Personal Information Disclosure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
16 Sep 2025to 26 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Emergency medicine physicians
  • Cardiologists
  • Hospitalists (i.e., internists whose practice is primarily in the hospital)
  • If there are duplicate participant IDs in the data, only the first response will be included in the analysis

Who cannot join

  • Participants who indicate they are retired
  • Participants who write gibberish in the open-ended items
  • Incomplete responses

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Van Munching Hall

    College Park, Maryland, 20742

Other trials in United States

About this study

Physicians often form quick judgments about the risk for serious disease when interacting with patients. Underestimating risk can lead to underuse of diagnostic testing and untreated illness, which can worsen patient outcomes. On the other hand, overestimating risk can lead to overuse of diagnostic testing, which is costly for health systems.

To form judgments of risk, physicians should attend to a host of validated factors that are predictive of disease. However, research suggests that physicians may rely on demographic factors-such as race and gender. Physicians' judgments could also be influenced by non-health-related, personal information about their patients (e.g., hobbies, nicknames), which may moderate the impact of demographics on those judgments.

Read more

The investigators examine these dynamics in the context of heart disease. The History, Electrocardiogram, Age, Risk factors and Troponin (HEART) Score is a validated model that specifies a correspondence between certain risk factors and the likelihood of Major Adverse Cardiac Event (MACE). Importantly, there are substantially different diagnostic tests (e.g., noninvasive stress test versus coronary angiogram) that should be used depending on a patient's MACE likelihood.

Specifically, the investigators have three research questions:

  • Research Question 1 (RQ1): How accurate are physicians relative to the benchmarks from the HEART score model?
  • Research Question 2 (RQ2): How do clinically-relevant risk factors (e.g., smoking history), race, gender, and personal information disclosure influence risk judgments?
  • Research Question 3 (RQ3): Does personal information disclosure moderate the effects of race and gender on risk judgments?

Note that when the investigators discuss accuracy and error, they are referring to the comparison of physician judgments to the HEART score model benchmarks.

Read the detailed description

The investigators designed a survey to assess physicians' perception of MACE likelihood. Each physician rates a panel of patient profiles. The profiles randomly vary in risk factors, race, gender, and personal information disclosure (e.g., non-health related information about their hobbies). Using the HEART Score model as a benchmark, the investigators will assess how accurately physicians perceive MACE Likelihood based on the risk factors in a given profile. The investigators will further estimate how race, gender, and personal information disclosure causally affect physician judgments.

To do this, the investigators designed a mixed-design experiment. Each participant will respond to eight patient profiles that vary along three fully-crossed within-subject factors: (i) race: black vs. white, (ii) gender: man vs. woman, and (iii) risk factors: low vs. medium risk (based on risk levels from the HEART score model). Each participant will also be randomly assigned (between-subjects) to (iv) either see non-health-related personal information (e.g., hobbies) for all eight of their patients, or not see this information for any of their patients. The investigators refer to each factor as a profile attribute.

For each profile, participants indicate the perceived risk of a major adverse cardiac event in the six weeks following the visit. Our primary outcome is a measure of absolute error in perceived risk of MACE (described under the Primary Outcome section). They also indicate the diagnostic test they believe is most appropriate (Secondary Outcome #4).

Analysis plan

For all analyses, the investigators will format the data such that there are eight observations per participant, each corresponding to a patient profile the participant responded to.

  • To test RQ1, the investigators will estimate an Ordinary Least Squares (OLS) regression predicting the primary outcome. The investigators will cluster standard errors by physician. The constant reflects the mean of our primary outcome, reflecting the extent to which physicians are inaccurate.
  • To test RQ2, the investigators will estimate an OLS regression predicting the primary outcome. The independent variables include four indicators to model the profile attributes: an indicator for risk factors, an indicator for gender, an indicator for race, and an indicator for personal information disclosure. The model will also include fixed effects for physician specialty (emergency medicine, cardiologists, and hospitalists). The investigators will cluster standard errors by physician.
  • To test RQ3, the investigators will reestimate the primary model testing RQ2 twice: In one model, the investigators will add an interaction term between personal information disclosure and race; and in the second model, the investigators will add an interaction term between personal information disclosure and gender.

As secondary analyses,

  • The investigators will estimate the models above except using Secondary Outcomes Measures #1-3
  • The investigators will measure participants' choice of appropriate diagnostic test for each patient as a secondary outcome (see Secondary Outcome #4). The investigators will estimate a multinomial logistic regression predicting choice of appropriate diagnostic test as the categorical outcome (with "routine follow-up" as the reference category). The independent variables include the four profile attribute indicators and physician specialty fixed effects. The investigators will cluster standard errors by physician.
  • The investigators will reestimate the primary models testing RQ2, except including pairwise interactions between the physician specialty fixed effects and each of the four attributes.
  • The investigators will reestimate the primary model testing RQ2, except adding all pairwise interactions between the four attributes as independent variables.
  • The investigators will measure overconfidence (see Secondary Outcome Measure #5). With data at the physician-level, the investigators will estimate an OLS regression predicting overconfidence. The investigators will reestimate the model, except adding the two indicators for physician specialty and the indicator for personal information disclosure as independent variables.

The investigators will also measure and explore (i) qualitative open-ended responses about how they made their risk estimations, (ii) whether participants use the HEART score model at their jobs (or another model), (iii) if they use a model, why they use it, (iv) if they have heard of the HEART score model, (v) if they looked up anything while taking the study, and (vi) if yes, what they looked up.

The investigators plan to recruit 300 physicians using the Medscape panel.

Being tested
Personal Information Disclosure
Keywords
Major Adverse Cardiac Event (MACE), Physician Perception, Risk Judgment, HEART Score, Diagnostic Testing, Cardiology, Personal Information

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personal Information DisclosureBehavioural

    Each profile also contains non-health related personal information that the patient has disclosed (e.g., nickname, hobbies).

Study groups in NCT07162376
Study groupRoleWhat they receive
No Personal Information DisclosureNo interventionParticipants rate 8 patient profiles of patients with chest pain. The profiles each contain info about the patient's race, gender, and risk factors associated with MACE.
Personal Information DisclosureExperimentalParticipants rate 8 patient profiles of patients with chest pain. The profiles each contain info about the patient's race, gender, and risk factors associated with MACE. Each profile also contains non-health related personal information that the patient has disclosed (e.g., nickname, hobbies).
Receives: Behavioral: Personal Information Disclosure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absolute Error in Perceived Risk of MACE

    For each patient profile, all participants will be asked about their perceived risk of MACE: What is the likelihood that this patient experiences a major adverse cardiac event in the six weeks following the visit? [0-100].

    The paradigm uses two levels of risk factors, each associated with a specific risk of MACE range as defined by the HEART score model: low risk factors = 0.9-1.7% (midpoint = 1.3%); and medium risk factors = 12-16.6% (midpoint = 14.3%). To calculate each participant's directional error, the investigators will take the difference between participants' perceived risk of MACE and the midpoint of the risk of MACE range from the HEART score model at each patient's corresponding risk level.

    The absolute error is calculated by taking the absolute value of the directional error.

    Measured: At the time of survey completion, within approximately 2 weeks

Secondary outcomes (5)
  1. Perceived Risk of MACE

    This reflects the raw, untransformed value of participants' response to the question: What is the likelihood that this patient experiences a major adverse cardiac event in the six weeks following the visit? [0-100].

    Measured: At the time of survey completion, within approximately 2 weeks

  2. Directional Error

    This reflects the directional error variable, explained under the primary outcome description.

    Measured: At the time of survey completion, within approximately 2 weeks

  3. Categorical Error

    This is a binary variable for whether participants' perceived risk of MACE falls outside of the HEART score model's risk of MACE range at each patient's corresponding risk level [1 = outside of the range; 0 = within than range].

    Measured: At the time of survey completion, within approximately 2 weeks

  4. Diagnostic Test Decision

    "What would you recommend for this patient?" [(a) Coronary computed tomography angiography (cCTA), (b) noninvasive stress test, (c) left heart catheterization (coronary angiogram with potential percutaneous coronary intervention), or (d) routine follow-up.]

    Measured: At the time of survey completion, within approximately 2 weeks

  5. Overconfidence

    "I believe my responses were more accurate than ____% of participants in this study." [0 to 100; there is more information in the survey about the meaning of "accurate" and the response options]. To measure true percentile placement, the investigators will calculate each participant's mean absolute error of perceived risk of MACE across the eight profiles and then calculate their percentile rank. The investigators will then calculate overconfidence by taking the difference between their perceived and true percentile placement. Note that this is specifically a measure of over-placement (rather than over-precision or over-estimation).

    Measured: At the time of survey completion, within approximately 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2025
  2. Study start16 Sep 2025
  3. Primary completion26 Sep 2025
  4. Study completion26 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel randomized trial at the physician level.
Masking
Single blind
Who is masked
Participant
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07162376
Sponsor's protocol ID
2281657-2
Status last verified
Sep 2025
First submitted
25 Aug 2025
Last updated
16 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The investigators will share anonymized responses from participants containing all their responses to our survey.

Questions about this trial

What is this clinical trial studying?

A study testing Personal Information Disclosure in people with Major Adverse Cardiac Event (MACE), run by University of Maryland, College Park at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absolute Error in Perceived Risk of MACE (time frame: At the time of survey completion, within approximately 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in